RETRACTED: Collagen prolyl hydroxylases are essential for breast cancer metastasis.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23539444.
- Also identified by DOI 10.1158/0008-5472.CAN-12-3963 and PMC identifier 3674184.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The presence of hypoxia and fibrosis within the primary tumor are two major risk factors for metastasis of human breast cancer. In this study, we demonstrate that hypoxia-inducible factor 1 activates the transcription of genes encoding collagen prolyl hydroxylases that are critical for collagen deposition by breast cancer cells. We show that expression of collagen prolyl hydroxylases promotes cancer cell alignment along collagen fibers, resulting in enhanced invasion and metastasis to lymph nodes and lungs. Finally, we establish the prognostic significance of collagen prolyl hydroxylase mRNA expression in human breast cancer biopsies and show that ethyl 3,4-dihydroxybenzoate, a prolyl hydroxylase inhibitor, decreases tumor fibrosis and metastasis in a mouse model of breast cancer.
Medical subject headings
- Breast Neoplasms
- Procollagen-Proline Dioxygenase